Clinical Trial Update: A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants [Phase 4]

View source ↗

Summary

A Phase 4 real-world cohort study of Pulmonary arterial hypertension participants sponsored by Actelion has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: TERMINATED